Outcomes in patients with chronic kidney disease referred late to nephrologists: A meta-analysis

被引:142
|
作者
Chan, Micah R.
Dall, Aaron T.
Fletcher, Kathlyn E.
Lu, Na
Trivedi, Hariprasad
机构
[1] Med Coll Wisconsin, Dept Med, Div Gen Internal Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Div Gen Internal Med, Zablocki Vet Adm Med Ctr, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Grad Sch Biomed Sci, Hlth Policy Inst, Div Biostat, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA
[5] Affiliated Hosp, Milwaukee, WI USA
关键词
chronic kidney disease; dialysis; hospitalization; mortality; referral; timing;
D O I
10.1016/j.amjmed.2007.04.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: The study purpose was to compare differences in mortality and the duration of hospitalization in patients with chronic kidney disease who are referred early versus late to nephrologists. METHODS: We searched English-language literature from 1980 through December 2005, along with national conference proceedings, the Web of Science Citation Index, and reference lists of all included studies. Twenty-two studies with a total sample size of 12,749 met inclusion criteria. RESULTS: There was significantly increased overall mortality in the late referral group as compared with the early referral group ( relative risk 1.99; 95% confidence interval [CI], 1.66 to 2.39, P <.0001). The duration of hospital stay, at the time of initiation of renal replacement therapy, was greater in the late referred group by an average of 12 days ( 95% CI, 8.0 to 16.1, P=.0007). Significant heterogeneity was detected for both outcomes. CONCLUSION: Timing of referral emerged to be a significant factor impacting homogeneity in the mortality outcome. Our results suggest significantly higher mortality and increased early hospitalization of chronic kidney disease subjects referred late to nephrologists as compared with earlier referred subjects. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1063 / U19
页数:10
相关论文
共 50 条
  • [41] Epidemiology, thrombolytic management, and outcomes of acute stroke among patients with chronic kidney disease: a systematic review and meta-analysis
    Zamberg, Ido
    Assouline-Reinmann, Marie
    Carrera, Emmanuel
    Sood, Manish M.
    Sozio, Stephen M.
    Martin, Pierre-Yves
    Mavrakanas, Thomas A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (07) : 1289 - 1301
  • [42] Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis
    Wenyuan Gan
    Wenli Chen
    Tianyu Li
    Danni Shao
    Fang Xu
    Shanshan Huo
    Chenchen Li
    Zhenhua Yang
    Xingruo Zeng
    International Urology and Nephrology, 2022, 54 : 1295 - 1302
  • [43] Cognition in chronic kidney disease: a systematic review and meta-analysis
    Berger, Israel
    Wu, Sunny
    Masson, Philip
    Kelly, Patrick J.
    Duthie, Fiona A.
    Whiteley, William
    Parker, Daniel
    Gillespie, David
    Webster, Angela C.
    BMC MEDICINE, 2016, 14
  • [44] Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis
    Duarte, Marvery P.
    Almeida, Lucas S.
    Neri, Silvia G. R.
    Oliveira, Juliana S.
    Wilkinson, Thomas J.
    Ribeiro, Heitor S.
    Lima, Ricardo M.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (02) : 501 - 512
  • [45] Effect of daprodustat on anemia in patients with chronic kidney disease: a meta-analysis
    Dengpiao Xie
    Jianting Wang
    Xinping Wu
    Mingquan Li
    International Urology and Nephrology, 2018, 50 : 2201 - 2206
  • [46] Association between sarcopenia and clinical outcomes in chronic kidney disease patients: A systematic review and meta-analysis
    Ribeiro, Heitor S.
    Neri, Silvia G. R.
    Oliveira, Juliana S.
    Bennett, Paul N.
    Viana, Joao L.
    Lima, Ricardo M.
    CLINICAL NUTRITION, 2022, 41 (05) : 1131 - 1140
  • [47] Effect of daprodustat on anemia in patients with chronic kidney disease: a meta-analysis
    Xie, Dengpiao
    Wang, Jianting
    Wu, Xinping
    Li, Mingquan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (12) : 2201 - 2206
  • [48] Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis
    Li, Ning
    Lv, Dan
    Zhu, Xiangjun
    Wei, Ping
    Gui, Yuan
    Liu, Shijia
    Zhou, Enchao
    Zheng, Min
    Zhou, Dong
    Zhang, Lu
    FRONTIERS IN MEDICINE, 2021, 8
  • [49] Predictors, prevalence and prognostic role of pulmonary hypertension in patients with chronic kidney disease: a systematic review and meta-analysis
    Lin, Chunlong
    Ge, Qilong
    Wang, Lei
    Zeng, Pan
    Huang, Mingmin
    Li, Dan
    RENAL FAILURE, 2024, 46 (02)
  • [50] Frailty and mortality among patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis
    Zhang, Quanchao
    Ma, Yingying
    Lin, Faying
    Zhao, Jinghong
    Xiong, Jiachuan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (02) : 363 - 370